States slow to cover GLP-1s for weight loss

Budget pressures have kept all but 13 states from covering GLP-1 drugs for weight loss through their Medicaid programs, a new report from KFF shows.

Why it matters: The restrictive policies add to equity concerns around the blockbuster drugs, which have shown a remarkable ability to help patients lose weight and improve associated health metrics.